New Targets = Better Standard of Care
Video Categories: Targeted Therapies
Alexander Bastian mentions that looking at more defined populations and leveraging the power of targeted medicine is improving the standard of care.
Linda Bosserman provides an overview of the nuances of personalized medicine as it relates to cost, value and access
Jayson Slotnik provides an overview of the issues in demonstrating the value of personalized medicine tests and products